In response to obesity and T2DM, it was found that the plasma levels of SFRP5 were significantly lower in Chinese obese individuals as well as T2DM subjects compared with normal subjects, in which SFRP5 was an independent factor influencing glucolipid metabolism, inflammation, and IR. This evidence concerns the gene SFRP5 and Obesity.